Baseline medication use associated with COVID-19 severity in people with rheumatic diseases
Due to sample size limitations, previous studies of DMARD use and COVID-19 outcomes have combined several different rheumatic diseases and medications, and investigated a single outcome—for example, the risk of hospitalization. ...